Loading the research desk…

Summit Therapeutics Inc. Common Stock (SMMT)

Publicly reported company facts and saved market data for Summit Therapeutics Inc. Common Stock (SMMT), with sources and as-of times. Saved data is not a live quote.

Company profile

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. Summit was founded in 2003 and the company's shares are listed on the Nasdaq Global Market (symbol "SMMT").

Company facts

Sector
Health Care
Industry
Pharmaceutical Preparations
Market cap
$12.4B
Incorporated in
Unavailable
Company website
www.smmttx.com
Exchange
NASDAQ

FennEdge notes

Sessions where SMMT appeared in the daily small-cap recap, newest first: opening gap, day change and the SEC filing or halt stored by the close. Facts with source links.

All daily recaps

Saved quote

Saved snapshot, not a real-time quote. Check the market time before relying on it.

Last reported price
$15.0501
Reported change
-3.03%
Reported volume
4,661,709
Latest market time

Short interest

Reported short interest
41,155,196 shares
Settlement date
Source
Nasdaq

Exchange-published short interest for the stated settlement date, not a live short position.

Recent daily sessions

The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.

SMMT daily open, high, low, close and volume
DateOpenHighLowCloseVolume
16.7916.7915.4615.527,131,981
17.4817.5917.0517.134,375,906
17.3617.6216.8217.595,755,325
17.6117.6416.8017.176,179,332
17.1018.3316.9817.958,175,297
17.4917.5316.5317.315,875,829
16.9717.6216.4417.275,277,704
16.9617.3216.6616.755,196,190
16.8217.5016.5916.697,900,981
16.5917.7216.1716.9113,060,430

Research this company

FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.

Sign in to continue